Cancer Commons founder Marty Tenenbaum, PhD, will speak at the 26th International Molecular Medicine Tri-Conference in San Francisco on March 12. At 8:15 am, he will moderate an expert panel discussion on “Data Science Enabling Personalized Medicine“: “Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak at the upcoming Bridging Clinical Research & Clinical Health Care Collaborative at the National Academy of Sciences in Washington, DC, on March 4 at 5:00 pm. Marty, who founded Cancer Commons after his own battle with melanoma, will facilitate an expert panel discussion on “Reinventing Clinical Research and Cancer Care.” That same day, he will also lead a lunchtime discussion… Read more »
I always say that Emma was an angel that appeared in my life. Rapidly, I saw that her advice was professional and that her insights matched the latest publications, so I have developed very strong trust in her… Moreover, what I appreciate the most about Emma is her human goodness and empathy. I have never felt I was just a case for her. She… Read more »
Cancer Commons leadership, including founder Marty Tenenbaum, executive director Erika Vial Monteverdi, and editor in chief George Lundberg, are speaking at the 2019 Precision Medicine World Conference (PMWC) in Silicon Valley. Every year, the conference attracts doctors, innovators, and patients “to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.” On… Read more »
The holiday season is an excellent time to reflect on the successes of the past year while looking forward to opportunities in the rapidly approaching new year. We want to express our deepest appreciation to the Cancer Commons community; everyone’s involvement and support have been integral to our progress and success this year. Our mission of leveraging the world’s best cancer knowledge to help advanced… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak at the NYC Oncology Investor Conference on October 30. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, “Can AI Cure Cancer?”: No one knows the optimal way to treat any cancer with currently available therapies.… Read more »
Last Saturday, Cancer Commons joined nearly 2,000 guests in Independence, MO, for a day full of music and celebration. Called Tomstock, this private, annual music festival raised funds for the H8 Cancer Foundation, a generous supporter of our organization. Cancer Commons received $100,000 of the proceeds from Tomstock 2018. Tomstock began five years ago when longtime friends Tom and Carman Duvall, and Kiers and Steve… Read more »
Erika Vial Monteverdi, Executive Director of Cancer Commons
Cancer Commons is happy to announce that Erika Vial Monteverdi has accepted the new position of Executive Director. Erika has played a central role at the organization since 2016. As Executive Director, she is now responsible for overseeing the growth and operations of Cancer Commons, one of Silicon Valley’s only nonprofits focused on serving cancer patients globally through aligning incentives around the patient to… Read more »
Cancer Commons founder Marty Tenenbaum, Ph.D., spoke on May 31 at Washington University in St. Louis during an invitation-only conference focused on new approaches to biomedical innovation. Marty, who founded Cancer Commons after his own battle with melanoma, participated in the “Opportunities and Challenges in Oncology Therapeutic Development” session, which explored promising new innovations that have not yet received the attention they merit. During the… Read more »
Cancer Commons founder Marty Tenenbaum, Ph.D., will speak May 11 at the Stanford AI Salon, a regular event hosted by the Stanford University Artificial Intelligence Laboratory. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments in a talk titled “How can AI cure cancer?” According to the event website, “AI… Read more »
Image credit: 
